181.55
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BIIB Giù?
Forum
Previsione
Frazionamento azionario
Biogen Inc Azioni (BIIB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
10.07%
2,279.40
|
2,534.70 | 2,645.50 | 2,431.00 | 2,465.80 |
| Cost Of Revenue |
26.53%
495.50
|
674.40 | 605.00 | 629.30 | 638.70 |
| Gross Profit |
4.11%
1,783.90
|
1,860.30 | 2,040.50 | 1,801.70 | 1,827.10 |
|
|
41.20%
1,839.90
|
1,303.00 | 1,296.50 | 1,490.50 | 1,376.10 |
| Interest Income/Expense |
0.15%
67.50
|
67.40 | 72.60 | 60.00 | 59.80 |
| Benefits Costs and Expenses |
18.10%
2,335.40
|
1,977.40 | 1,901.50 | 2,119.80 | 2,014.80 |
| Costs And Expenses |
18.10%
2,335.40
|
1,977.40 | 1,901.50 | 2,119.80 | 2,014.80 |
| Operating Income/Loss |
110.05%
-56.00
|
557.30 | 744.00 | 311.20 | 451.00 |
| Income/Loss From Continuing Operations Before Tax |
110.05%
-56.00
|
557.30 | 744.00 | 311.20 | 451.00 |
| Income Tax Expense/Benefit, Deferred |
34.24%
166.90
|
253.80 | -31.30 | -27.80 | -52.60 |
| Income Tax Expense/Benefit |
107.82%
-7.10
|
90.80 | 109.20 | 70.70 | 62.50 |
| Income/Loss From Continuing Operations After Tax |
110.48%
-48.90
|
466.50 | 634.80 | 240.50 | 388.50 |
|
|
110.48%
-48.90
|
466.50 | 634.80 | 240.50 | 388.50 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.93%
0.10
|
146.60 | 146.50 | 146.10 | 145.70 |
| Diluted Average Shares |
99.80%
0.30
|
147.10 | 146.70 | 146.60 | 146.10 |
| Basic Earnings Per Share |
110.38%
-0.33
|
3.18 | 4.33 | 1.65 | 2.67 |
| Diluted Earnings Per Share |
111.04%
-0.35
|
3.17 | 4.33 | 1.64 | 2.66 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):